Serum Autotaxin Levels Predict Liver-Related Events in Patients With Primary Biliary Cholangitis: A Long-Term Multicenter Observational Study
Authors:
- Takanobu IwadareTITakanobu Iwadare
- Takefumi KimuraTKTakefumi Kimura
- Yuki YamashitaYYYuki Yamashita
- Taiki OkumuraTOTaiki Okumura
- Shun-Ichi WakabayashiSWShun-Ichi Wakabayashi
- Hiroyuki KobayashiHKHiroyuki Kobayashi
- Ayumi SugiuraASAyumi Sugiura
- Tomoo YamazakiTYTomoo Yamazaki
- Satoshi ShimamotoSSSatoshi Shimamoto
- Koji IgarashiKIKoji Igarashi
- Satoru JoshitaSJSatoru Joshita
- Takeji UmemuraTUTakeji Umemura
Open Access
- 17 October 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 15 (12) , e00779
Abstract
INTRODUCTION: A straightforward, reliable, and noninvasive method for predicting the development of liver-related events (LRE) in primary biliary cholangitis (PBC) has not been attained thus far. This study investigated whether serum autotaxin (ATX) could predict LRE in patients with PBC. METHODS: This retrospective multicenter investigation included 190 biopsy-proven untreated patients with PBC. All subjects were followed for at least 1 year, during which time the prevalence of LRE, including newly developing hepatocellular carcinoma, esophagogastric varices, ascites, and hepatic encephalopathy, was investigated in relation with ATX levels at the time of liver biopsy. RESULTS: During the median follow-up period of 9.7 years, LRE were observed in 22 patients (11.6%). The area under the receiver operating characteristic curve and cutoff value of serum ATX for predicting LRE were 0.80 and 1.086 mg/L, respectively. Patients with serum ATX ≥1.086 had a significantly higher cumulative incidence of LRE compared with patients with ATX < 1.086 (33.3% vs 3.6%, P < 0.00001). Notably, the predictive capability of ATX for LRE in patients with PBC surpassed that of FIB-4, ALBI, APRI, and Mac-2-binding protein glycan isomer. A multivariate Cox proportional hazards model revealed ATX as an independent associated factor for LRE (hazard ratio 6.24, 95% confidence interval 1.87–20.80, P = 0.003) along with Nakanuma stage (hazard ratio 2.75, 95% confidence interval 1.52–4.99, P < 0.001). These results were closely replicated in a serologically diagnosed PBC validation cohort (n = 32). DISCUSSION: Serum ATX levels may serve as a predictive marker for LRE in patients with PBC.Keywords
Funding Information
- Japan Society for the Promotion of Science London (JP22K20884)
- Japan Agency for Medical Research and Development (JP23fk0210125)
This publication has 45 references indexed in Scilit:
- Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis CAnnals of Hepatology, 2022
- Roles for lysophosphatidic acid signaling in vascular development and diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2020
- Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysisHepatology International, 2019
- Lysophosphatidic acid receptor, LPA6, regulates endothelial blood-brain barrier function: Implication for hepatic encephalopathyBiochemical and Biophysical Research Communications, 2018
- Hepatocyte autotaxin expression promotes liver fibrosis and cancerHepatology, 2017
- Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventionsHepatology, 2012
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Primary biliary cirrhosis # †Hepatology, 2009
- FIB-4Hepatology, 2007
- Effects of Lysophosphatidic Acid on Proliferation of Stellate Cells and Hepatocytes in CultureBiochemical and Biophysical Research Communications, 1998